Ctnnb1 Xenograft-Applicable mouse models

To model Wnt signaling accurately, researchers must target Ctnnb1, the mouse ortholog of human CTNNB1, which encodes β-catenin, the central cytosolic pool and transcriptional effector of the canonical Wnt pathway. Upon pathway activation, β-catenin escapes destruction-complex phosphorylation, accumulates, and translocates to the nucleus to bind TCF/LEF factors, driving genes linked to stemness and oncogenesis. Consequently, model designs must explicitly separate absolute pathway collapse (via conditional null alleles) from hyperactivation (via exon 3 deletion or degron-evading mutations) or epitope-matched humanization for therapeutic antibody testing. Because homologous cadherin-associated or plakoglobin family members can functionally compensate for local loss, planning compound conditional genetics early prevents the discovery of masked phenotypes after a single-locus knockout. Ultimately, matching the specific Ctnnb1 allele class to your endpoint, whether assessing downstream signaling readouts, tumor latency in cooperation with partners like Apc, or drug response, is critical, as a trusted, validated Cre driver is just as vital as the flox design itself.

Work with your strain choice to align human tumor models with the immune profile you need.